Event Type: single-event

DAPA Presents… PRESENTATION & Dinner from GSK: Implementing Shingrix with Eric Crumbaugh, PharmD, Director of Clinical Business Development for ExpressRx Hosted by Lee Gatewood Followed by our SOCIAL EVENT… Happy Hour until 9 PM! (Happy Hour Drink prices for all those attending the meeting until 9 PM) Thursday, October 14 6:00 PM Seasons 52 in Read moreOctober – GSK – a Meeting & a Social 2021

We’re excited to announce our first “hybrid” in-person & virtual meeting this October. Presentation Topic: Oriahnn An Oral Treatment for Heavy Bleeding Due to Fibroids in Premenopausal Women PRESENTED BY DENNIS SONG, President of Denton County Pharmacy Association HOSTED BY AARON AUSTIN OF ABBVIE Location: 2440 Parkwood Blvd, Frisco, TX 75034 Date & Time: Thursday, October Read moreOctober 2021 “Hybrid” Meeting – Abbvie

WEBINAR 2: Thursday, June 24 – 6PM CT UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids Read moreDAPA & AbbVie – Women’s Health Sessions – Session 2 – Thursday, June 24

  WEBINAR 1: Wednesday, June 23, 2021 – 6PM CT  Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain. One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth Read moreDAPA & AbbVie – Women’s Health Sessions – Session 1 – Wednesday, June 23

Rare Genetic Diseases of Obesity:   Challenges and Patient Cases – Virtual Meeting Thursday, May 6, 2021 6:30 PM The disease education event will explain the role of the hypothalamic signaling pathway in appetite, energy and weight regulation.  The presentation will include how impairments in the melanocortin-4 receptor (MC4R) pathway may lead to insatiable hunger and Read moreMay 2021 – Rhythm Pharmaceuticals – DAPA – Rare Genetic Diseases of Obesity: Challenges and Patient Cases

  You’re invited to join our April 2021 Meeting! Title Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF) Presented by Jessica Hart, PharmD, BCACP – Medical Science Liaison, Cardiovascular and Metabolic – North Texas, Oklahoma, AstraZeneca When Thursday, April 8, 2021 at 6:30 PM This is a VIRTUAL meeting Are Read moreApril 2021 DAPA Meeting – AstraZeneca – Use of Dapagliflozin in Patients with Heart Failure with reduced Ejection Fraction (HFrEF)